Diagnostic Validity of Serum Macrophage Inhibitor Cytokine and Tissue Polypeptide-Specific Antigen in Pancreatobiliary Diseases
- 1 September 2011
- journal article
- Published by Elsevier BV in Pancreatology
- Vol. 11 (3), 295-300
- https://doi.org/10.1159/000328963
Abstract
Macrophage inhibitory cytokine (MIC-1) and tissue polypeptide-specific antigen (TPS) are novel markers for several inflammatory and malignant disorders, and there are no sufficient data about the utility of these antigens as serum tumor markers. We aimed at measuring the serum levels of MIC-1 and TPS in patients with benign and malignant pancreatobiliary diseases and at determining their diagnostic efficacy. Sera collected from patients with pancreatic adenocarcinomas (56 cases), periampullary carcinomas other than pancreatic carcinomas (15 cases), benign pancreatic diseases (31 cases), benign biliary diseases (15 cases) and healthy volunteers (33 cases) were analyzed for MIC-1 and TPS and the results were compared with CA 19-9. Serum MIC-1 levels increased more significantly in patients with pancreatic carcinomas than in patients with benign pancreatobiliary diseases and healthy controls (p < 0.05). MIC-1 has a similar sensitivity (81%) but a lower specificity (73 vs. 97%) than CA 19-9 in patients with pancreatic carcinomas. Serum TPS was comparable among patients with malignant and benign pancreatobiliary diseases, and healthy controls. MIC-1 is a valuable tumor marker for the diagnosis of pancreatic cancer. It has a good correlation with CA 19-9. TPS has no diagnostic importance to differentiate pancreatobiliary diseases. and IAP.This publication has 23 references indexed in Scilit:
- Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortalityAging Cell, 2010
- Identification of Macrophage Inhibitory Cytokine-1 in Adipose Tissue and Its Secretion as an Adipokine by Human AdipocytesEndocrinology, 2008
- Role of Macrophage Inhibitory Cytokine-1 in Tumorigenesis and Diagnosis of CancerCancer Research, 2006
- Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9Clinical Cancer Research, 2006
- The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cellsCarcinogenesis: Integrative Cancer Research, 2005
- Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissuesBritish Journal of Cancer, 2003
- Expression of growth differentiation factor‐15/ macrophage inhibitory cytokine‐1 (GDF‐15/MIC‐1) in the perinatal, adult, and injured rat brainJournal of Comparative Neurology, 2001
- Expression of a novel member of the TGF-β superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissuesCell and tissue research, 1999
- MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activationJournal of Leukocyte Biology, 1999
- MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamilyProceedings of the National Academy of Sciences of the United States of America, 1997